News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,500 Results
Type
Article (46539)
Company Profile (256)
Press Release (612705)
Section
Business (188707)
Career Advice (2589)
Deals (33971)
Drug Delivery (119)
Drug Development (80737)
Employer Resources (158)
FDA (16045)
Job Trends (14768)
News (327870)
Policy (32277)
Tag
Academia (2754)
Alliances (48349)
Alzheimer's disease (1373)
Approvals (16010)
Artificial intelligence (231)
Bankruptcy (336)
Best Places to Work (11540)
Biotechnology (147)
Breast cancer (228)
Cancer (1777)
Cardiovascular disease (142)
Career advice (2164)
CAR-T (130)
Cell therapy (369)
Clinical research (65103)
Collaboration (702)
Compensation (283)
COVID-19 (2618)
C-suite (171)
Data (1639)
Diabetes (224)
Diagnostics (6256)
Earnings (70358)
Employer resources (142)
Events (100152)
Executive appointments (598)
FDA (16958)
Funding (625)
Gene therapy (268)
GLP-1 (732)
Government (4497)
Healthcare (18353)
Infectious disease (2739)
Interviews (529)
IPO (15161)
Job creations (3689)
Job search strategy (1791)
Layoffs (466)
Legal (7470)
Lung cancer (271)
Manufacturing (252)
Medical device (12975)
Medtech (12980)
Mergers & acquisitions (19185)
Metabolic disorders (605)
Neuroscience (1817)
NextGen: Class of 2025 (6450)
Non-profit (4486)
Northern California (1929)
Obesity (338)
Opinion (243)
Patents (169)
People (57781)
Phase I (20132)
Phase II (28644)
Phase III (21599)
Pipeline (729)
Postmarket research (2590)
Preclinical (8282)
Radiopharmaceuticals (252)
Rare diseases (342)
Real estate (5708)
Regulatory (22113)
Research institute (2438)
Resumes & cover letters (386)
Southern California (1702)
Startups (3485)
United States (17790)
Vaccines (619)
Weight loss (252)
Date
Today (44)
Last 7 days (590)
Last 30 days (2626)
Last 365 days (34309)
2025 (4483)
2024 (35033)
2023 (39370)
2022 (50124)
2021 (54411)
2020 (53066)
2019 (46640)
2018 (35364)
2017 (32522)
2016 (31724)
2015 (36761)
2014 (29341)
2013 (24433)
2012 (26158)
2011 (26785)
2010 (24231)
Location
Africa (856)
Arizona (158)
Asia (41315)
Australia (7409)
California (4463)
Canada (1695)
China (405)
Colorado (220)
Connecticut (218)
Europe (90220)
Florida (679)
Georgia (161)
Illinois (461)
Indiana (274)
Japan (123)
Maryland (740)
Massachusetts (3415)
Michigan (201)
Minnesota (334)
New Jersey (1342)
New York (1340)
North Carolina (850)
Northern California (1929)
Ohio (169)
Pennsylvania (1040)
South America (1191)
Southern California (1702)
Texas (675)
Utah (143)
Washington State (444)
659,500 Results for "innovation pharma formerly known as cellceutix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment
February 19, 2025
·
3 min read
Press Releases
Fosun Pharma Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation
February 17, 2025
·
7 min read
Government
Trump’s Whiplash Policies Keep Pharmas on Their Toes
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives find themselves faced with policy questions ranging from the Inflation Reduction Act to RFK Jr.
February 12, 2025
·
4 min read
·
Annalee Armstrong
GLP-1
Lilly, Novo Skew Overall Pharma Trends With Colossal GLP-1 Sales Growth
From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved into a new pharma stratosphere, far eclipsing their rivals.
February 12, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
February 12, 2025
·
4 min read
Press Releases
Exxel Pharma’s Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
February 3, 2025
·
6 min read
Genetown
Nxera Pharma joins the World Orphan Drug Alliance
Nxera Pharma Co. Ltd – formerly known as Sosei Group or Sosei Heptares – announces it has joined the World Orphan Drug Alliance, a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in complex markets around the world.
April 8, 2024
·
4 min read
1 of 65,950
Next
